Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

16.07
+0.20001.26%
Volume:1.08M
Turnover:17.40M
Market Cap:1.91B
PE:-13.88
High:16.70
Open:16.03
Low:15.70
Close:15.87
Loading ...

Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?

Zacks
·
28 Jan

Arcutis Biotherapeutics Receives Buy Rating Amid Strong Prescription Growth in Zoryve Franchise

TIPRANKS
·
27 Jan

Strong Prescription Growth for Arcutis Biotherapeutics’ Zoryve Franchise Supports Buy Rating

TIPRANKS
·
20 Jan

Arcutis Biotherapeutics price target raised to $20 from $18 at Needham

TIPRANKS
·
13 Jan

Arcutis Shares Climb on Strong Product Revenue Estimates

Dow Jones
·
13 Jan

Arcutis Biotherapeutics Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Jan

Arcutis Biotherapeutics’ Robust Revenue Growth and Strategic Financial Positioning Underpin Buy Rating

TIPRANKS
·
13 Jan

Arcutis Biotherapeutics: Strong Sales and Strategic Growth Drive Buy Rating

TIPRANKS
·
13 Jan

Arcutis Biotherapeutics Expects Fiscal Q4 Revenue to Soar Driven by Zoryve Demand

MT Newswires Live
·
13 Jan

Strong Financial Performance and Growth Prospects Drive Buy Rating for Arcutis Biotherapeutics

TIPRANKS
·
13 Jan

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hologic (HOLX) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
13 Jan

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million

THOMSON REUTERS
·
12 Jan

High Growth Tech Stocks In The United States To Watch

Simply Wall St.
·
10 Jan

Arcutis Biotherapeutics Is Maintained at Outperform by Mizuho

Dow Jones
·
08 Jan

U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Reuters
·
07 Jan

Arcutis Biotherapeutics (ARQT) Gets a Buy from Mizuho Securities

TIPRANKS
·
07 Jan